Tag Archives: antibody therapy

Encouraging clinical results for an antibody drug to prevent or treat HIV

Encouraging results for an antibody drug to prevent or treat HIVA drug known as 10-1074, based on a human antibody against HIV, has dramatically reduced virus levels in patients and appeared to prevent infection among those at high risk, according to data from a new clinical trial. More »

Tags: , , , , , , , ,

Antibody Combination Puts HIV on the Ropes

Antibody combination puts HIV on the ropesResearchers have shown that a combination of three antibody drugs can completely suppress HIV in infected mice. The antibodies were isolated from a patient whose immune system mounted an unusually effective response against the virus. More »

Tags: , , , , , ,

New antibody drug continues to show promise for treatment of HIV

New antibody drug continues to show promise for treatment of HIVAntibody therapy may offer an alternative to standard HIV treatments, which require a strict regimen and can cause complications in the long-term. New results from a clinical trial show that the 3BNC117 antibody can significantly delay the virus from rebounding in patients taken off their current medications. More »

Tags: , , , , ,

In the News – Los Angeles Times – Nussenzweig

New therapy keeps HIV at bay without daily drug regimen, study says   “Using antibodies against HIV could be part of a ‘kick and kill’ strategy, said study co-author Dr. Michel Nussenzweig — to kick the virus out of its … More »

Tags: , , , ,

Michel C. Nussenzweig honored with the 2016 Robert Koch Award

Michel C. Nussenzweig honored with the 2016 Robert Koch AwardGiven by the Robert Koch Foundation, the annual award is one of Germany’s most prestigious scientific prizes, honoring extraordinary accomplishments in infectious disease research. Nussenzweig will share the €100,000 prize with Alberto Mantovani of Humanitas University for their achievements in immunology. More »

Tags: , , , , ,

Tri-Institutional Therapeutics Discovery Institute expands focus to include antibody drug discovery research

Tri-Institutional Therapeutics Discovery Institute expands focus to include antibody drug discovery researchThe Tri-I TDI, a partnership established in 2013 to expedite early-stage drug discovery of innovative new small molecule therapies, announced today that it will expand its scope to support the development of antibody drug discovery. More »

Tags: , ,

Antibody therapy opens door to potential new treatment for HIV

Antibody Therapy Opens Door to Potential New Treatment for HIVResearchers are developing an antibody-based drug that may provide a better strategy for long-term control of HIV. New results from a clinical trial suggest that a single dose of a so-called broadly neutralizing antibody enables patients’ immune systems to better fight the virus. More »

Tags: , , , , ,

New antibody therapy dramatically improves psoriasis symptoms in clinical trial

New antibody therapy dramatically improves psoriasis symptoms in clinical trialOnly a single treatment produced what researchers describe as “rapid, substantial, and durable clinical improvement” in patients. This raises the prospect of a treatment that could put this autoimmune disease of the skin into long-term remission. More »

Tags: , , , , ,